Equity mutual funds attracted net inflows of ₹25,978 crore in February, marking an 8 per cent rise from the previous month amid the India-US trade deal.
HDFC AMC, UTI AMC shares fell today as investors assessed the impact of new MF rules.Sebi has introduced Life Cycle Funds, capped sectoral overlap, and allowed value & contra co-existence
UTI AMC reported an in-line operating performance in Q3FY26, although reported profitability was impacted by a one-time VRS charge, according to Antique Stock Broking
Analysts have been positive on AMC space, considering the levers of stable systematic investments and a better yield outlook now led by the passage of recent regulations on total expense ratio (TER).
AMCs in focus: The Sebi overhauled the cost framework for the MF industry, introducing a simplified structure aimed at improving transparency for investors while balancing the impact on asset managers
According to the analysts, disbursement growth remained soft across most lenders in Q2FY26 due to seasonality and increased caution in SME/MSME segments.
UTI AMC names Vetri Subramaniam as next MD & CEO from Feb 2026, while Bandhan AMC secures SEBI nod to launch specialised investment funds under its new brand
Shares of HDFC AMC, NAM-India, UTI AMC and Aditya Birla AMC were quoting at record highs levels; following a sharp rebound from the calendar year lows. Here's a likely guide on the near-term trend.
AMC stocks India: UTI Asset Management Company (UTI AMC) shares hit a record high of ₹1,428 per share on the BSE, rising 6.3 per cent in the intraday trade
UTI AMC stock: Analysts believe that improving capital market returns are expected to boost equity AUM growth, aiding the topline and treasury gains for Asset Management Companies.
Stock exchanges are bracing for an impact on the turnover in index derivatives as three of the six new norms to curb participation in the futures & options segment come into effect from November 20
In past three days, the stock surged 18% after UTI AMC reported a 31% YoY jump in PAT at Rs 239 crore for Q2FY25, led by steady revenue yield and moderation in the expense ratio.